Alain Leizorovicz
Faculté de Médecine Laënnec
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alain Leizorovicz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:01 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT00277394 · Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein ThrombosisLEO Pharma · completed · Deep Vein Thrombosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:01 UTC. The ranking covers the 200 most relevant of 56 PubMed records, and a shared surname and initials can bring in a namesake. All 56 on PubMed
- 1,264 citationsRCR 44.2
- 1,261 citationsRCR 37.4
- Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.Circulation · 2004735 citationsRCR 19.7
- Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.N Engl J Med · 2011440 citationsRCR 13.8
- Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.Lancet · 2002418 citationsRCR 9.0
- Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.Circulation · 2001411 citationsRCR 10.3
- Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.Circulation · 2003374 citationsRCR 8.2
- 356 citationsRCR 16.6
- 350 citationsRCR 16.4
- Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.Kidney Int · 2006254 citationsRCR 6.6